Alzheimer's Disease Drug Development

Publisher : Cambridge University Press

ISBN-13 : 1108838669

Page : 387 pages

Rating : 4.5/5 from 669 voters

Provides a definitive overview of the complex ecosystem facilitating Alzheimer's Disease drug research and development. Demonstrates a drug's journey from in the lab, clinical trial testing, regulatory review, and marketing by pharmaceutical companies. Details the use of artificial intelligence, clinical trial management, and financing models.

More Books:

Alzheimer's Disease Drug Development
Language: en
Pages: 387
Authors: Jeffrey Cummings
Categories: Medical
Type: BOOK - Published: 2022-03-31 - Publisher: Cambridge University Press

Provides a definitive overview of the complex ecosystem facilitating Alzheimer's Disease drug research and development. Demonstrates a drug's journey from in th
Biomarkers for Alzheimer's Disease Drug Development
Language: en
Pages: 372
Authors: Robert Perneczky
Categories: Alzheimer's disease
Type: BOOK - Published: 2018 - Publisher:

This volume aims to build a new generation of experts with a broader understanding of key topics in the Alzheimers disease field. Chapters guide readers through
Immune Dysfunctions
Language: en
Pages:
Authors:
Categories:
Type: BOOK - Published: 1988 - Publisher:

Global Clinical Trials for Alzheimer's Disease
Language: en
Pages: 432
Authors: Menghis Bairu
Categories: Medical
Type: BOOK - Published: 2013-08-28 - Publisher: Academic Press

Global Clinical Trials for Alzheimer’s Disease is a handy one-stop reference for researchers and physicians planning and conducting global clinical trials in
Modulation of Protein-protein Interactions for Drug Development in Alzheimerʼs Disease
Language: en
Pages:
Authors: Sara Iozzi
Categories:
Type: BOOK - Published: 2011 - Publisher:

Alzheimer's Disease - Modernizing Concept, Biological Diagnosis and Therapy
Language: en
Pages: 200
Authors: M.C. Carrillo
Categories: Medical
Type: BOOK - Published: 2012-04-23 - Publisher: Karger Medical and Scientific Publishers

Expanding knowledge on genetic and epigenetic risk factors is rapidly enhancing our understanding of the complex molecular interactions and systems involved in
Design of Hybrid Molecules for Drug Development
Language: en
Pages: 352
Authors: Michael Decker
Categories: Science
Type: BOOK - Published: 2017-04-05 - Publisher: Elsevier

Design of Hybrid Molecules for Drug Development reviews the principles, advantages, and limitations involved with designing these groundbreaking compounds. Begi
Global Clinical Trials for Alzheimer’s Disease
Language: en
Pages: 432
Authors: Hans J. Möbius
Categories: Medical
Type: BOOK - Published: 2013-08-28 - Publisher: Elsevier Inc. Chapters

Regulatory approval of the first rational AD therapeutic tacrine occurred in 1993, followed by the approval of three other, AChEIs, and the NMDA antagonist mema
Drug Design and Discovery in Alzheimer’s Disease
Language: en
Pages: 784
Authors: Atta-ur-Rahman
Categories: Science
Type: BOOK - Published: 2015-06-27 - Publisher: Elsevier

Drug Design and Discovery in Alzheimer’s Disease includes expert reviews of recent developments in Alzheimer's disease (AD) and neurodegenerative disease rese
Developing Therapeutics for Alzheimer's Disease
Language: en
Pages: 676
Authors: Michael S. Wolfe
Categories: Medical
Type: BOOK - Published: 2016-05-27 - Publisher: Academic Press

Developing Therapeutics for Alzheimer's Disease: Progress and Challenges provides a thorough overview of the latest advances toward the development of therapeut